BamSEC and AlphaSense Join Forces
Learn More

Achillion Pharmaceuticals Inc

Formerly NASDAQ: ACHN

Material Contracts Filter

EX-10.1
from 10-Q 56 pages Sublease by and Between Yale University (Sublandlord) and Achillion Pharmaceuticals, Inc. (Subtenant) Dated: September 13, 2019 Sublease Dated: September 13, 2019 Reference Data
12/34/56
EX-10.19
from 10-K 2 pages Achillion Pharmaceuticals, Inc. Non-Executive Directors Compensation Policy
12/34/56
EX-10.1
from 8-K 13 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 14 pages Amendment to Lease
12/34/56
EX-10.1
from 8-K 39 pages Lease Agreement Sentry Kpg III, L.P. Landlord and Achillion Pharmaceuticals, Inc. Tenant at Veva 14 1777 Sentry Parkway West Blue Bell, Pennsylvania July 20, 2018 Lease Agreement
12/34/56
EX-10.1
from 8-K 8 pages Via Email and Overnight Delivery November 7, 2018 Dear Mary Kay: As We Discussed, This Letter Agreement Confirms the Terms of Your Transition and Separation From Employment With, and All Offices In, Achillion Pharmaceuticals, Inc. (The “Company”), Effective December 28, 2018 (The “Separation Date”)
12/34/56
EX-10.3
from 10-Q 13 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 13 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 13 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 13 pages Employment Agreement
12/34/56
EX-10.4
from 10-Q 6 pages Via Overnight Mail and Hand Delivery May 1, 2018 Milind Deshpande, PH.D. 44 Field Brook Road Madison, Ct 06443 Dear Milind
12/34/56
EX-10.3
from 10-Q 11 pages Achillion Pharmaceuticals, Inc. Amended and Restated 2015 Stock Incentive Plan
12/34/56
EX-10.2
from 10-Q 10 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 15 pages Second Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K 4 pages Johnson & Johnson Innovation-Jjdc, Inc. 410 George Street New Brunswick, New Jersey 08901 Re: Letter Agreement Release and Amendment to Investor Agreement Ladies and Gentlemen
12/34/56
EX-10.2
from 10-Q 5 pages Amendment No. 5 to Lease
12/34/56
EX-10.1
from 10-Q 10 pages Achillion Pharmaceuticals, Inc. Nonstatutory Stock Option Agreement Inducement Grant Pursuant to NASDAQ Stock Market Rule 5635
12/34/56
EX-10.6
from 10-Q 10 pages First Amendment to Master Security Agreement
12/34/56
EX-10.5
from 10-Q 14 pages Amended and Restated Employment Agreement
12/34/56
EX-10.4
from 10-Q 14 pages Amended and Restated Employment Agreement
12/34/56